Source-linked trial list

The registrations behind this number.

Verify the exact trial registrations behind a company, intervention, programme or topic count.

Exact trial list

3 matching trial registrations

Intervention OTX-TKI

Showing 1–3 of 3. Every record below meets all the filters shown above.

RecruitingNCT07516132

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

PHASE3 · 850 planned enrolment

Countries listed: 1
Registry update: July 1, 2026

Verify in the registry →

Active Not RecruitingNCT06495918

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

PHASE3 · 825 planned enrolment

Countries listed: 4
Registry update: June 17, 2025

Verify in the registry →

CompletedNCT03630315

CLN-0046: Treatment of AMD Subjects With OTX-TKI

PHASE1 · 29 planned enrolment

Countries listed: 1
Registry update: July 10, 2024

Verify in the registry →